Stocks · Health care · Biological Products, (No Diagnostic Substances)

Scholar Rock Holding Corp

SRRK Clue Score46
United States Fiscal year ends December CIK 0001727196 Results filed 6 Aug 2026

What the insiders did Balanced

By person

31 insiders · 194 transactions
106×

David Hallal holds 106 times base salary in stock. $68.17M of shares against $637.50K in salary for 2025.

Salary from the company's own proxy. The shares are what David Hallal last reported holding, valued at $41.59, the price Common Stock was last bought or sold at on the open market here, on 26 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Invus Public Equities, L.P.
10% owner
$17.55M (7)
$82.41M (7)
−$64.86M
9,250,005
7.60%
$384.71M
+5.7%
Edward H Myles
COO & CFO
—
$16.81M (19) scheduled
−$16.81M
111,345
0.0914%
$4.63M
−70.1%
Samsara BioCapital GP, LLC entity
10% owner
$15.00M (1)
—
+$15.00M
6,788,609
5.57%
$282.34M
+47.6%
Mo Qatanani
Chief Scientific Officer
—
$13.37M (24) scheduled
−$13.37M
98,445
0.0808%
$4.09M
−0.5%
Srinivas Akkaraju
Director
$46.99M (16)
$34.39M (3) scheduled
+$12.60M
13,499,122
11.08%
$561.43M
+27.7%
Amir Nashat
Director
$7.87M (4)
—
+$7.87M
38,639
0.0317%
$1.61M
—
International S.C.A. Artal
10% owner
$6.30M (1)
—
+$6.30M
2,396,040
1.97%
$99.65M
—
Jing L. Marantz
Chief Medical Officer
—
$4.06M (12) scheduled
−$4.06M
126,012
0.1035%
$5.24M
—
David Hallal
Chief Executive Officer
—
$3.97M (2)
−$3.97M
1,844,034
1.51%
$76.69M
+245.2%
Gregory John Carven
Chief Scientific Officer
—
$3.27M (8) scheduled
−$3.27M
128,208
0.1053%
$5.33M
+134.8%
Jeffrey S. Flier
Director
—
$2.21M (13) scheduled
−$2.21M
27,856
0.0229%
$1.16M
−36.4%
Polaris Venture Management Co. VI, L.L.C. entity
10% owner
$2.00M (2)
—
+$2.00M
156,395
0.1284%
$6.50M
—
Jay T. Backstrom
Chief Executive Officer
—
$1.85M (3)
−$1.85M
425,561
0.3494%
$17.70M
—
Junlin Ho
General Counsel
—
$1.82M (8)
−$1.82M
241,545
0.1983%
$10.05M
+525.2%
Akshay Vaishnaw
President of R&D
—
$1.68M (4)
−$1.68M
630,542
0.5177%
$26.22M
+6,569%
Caryn Parlavecchio
CHRO
—
$1.63M (11)
−$1.63M
169,087
0.1388%
$7.03M
+281.7%
Tracey Sacco
Chief Commercial Officer
—
$1.32M (7) scheduled
−$1.32M
71,750
0.0589%
$2.98M
—
Vikas Sinha
Chief Financial Officer
—
$1.23M (2)
−$1.23M
619,856
0.5090%
$25.78M
—
Keith Woods
Chief Operating Officer
—
$1.22M (2)
−$1.22M
620,055
0.5091%
$25.79M
+1,191%
Timothy A Springer
10% owner
$999.99K (1)
—
+$999.99K
2,376,567
1.95%
$98.84M
+64.5%
Michael Gilman
Director
—
$870.19K (10) scheduled
−$870.19K
59,511
0.0489%
$2.48M
+35.4%
Katie Peng
Director
—
$502.00K (10) scheduled
−$502.00K
34,301
0.0282%
$1.43M
—
Erin Moore
Interim PFO and PAO
—
$449.24K (1) scheduled
−$449.24K
82,609
0.0678%
$3.44M
0.0%
Kristina Burow
Director
—
$324.57K (4) scheduled
−$324.57K
2,460,368
2.02%
$102.33M
—
Joshua Reed
Director
—
$324.53K (4) scheduled
−$324.53K
19,518
0.0160%
$811.75K
—
Richard Brudnick
Director
—
$180.53K (2) scheduled
−$180.53K
21,896
0.0180%
$910.65K
—
Invus Global Management, LLC entity
10% owner
—
—
—
10,825,013
8.89%
$450.21M
+17.0%
ARCH Venture Fund VIII, L.P. entity
10% owner
—
—
—
2,637,617
2.17%
$109.70M
—
Nagesh K. Mahanthappa
Interim CEO and President
—
—
—
480,491
0.3945%
$19.98M
+26.3%
Yung H. Chyung
Chief Medical Officer
—
—
—
258,496
0.2123%
$10.75M
+25.1%
Stuart A Kingsley
President and CEO
—
—
—
42,000
0.0345%
$1.75M
—